Filtered By:
Vaccination: Varicella-Zoster Virus Vaccine
This page shows you your search results in order of relevance. This is page number 6.
Order by Relevance | Date
Total 2327 results found since Jan 2013.
A study on knowledge, attitude, and vaccination behavior of herpes zoster vaccine among urban residents in selected areas of China
Conclusion: Low knowledge of herpes zoster and its vaccine, positive attitudes towards the preventive effects of herpes zoster and its vaccine, and extremely low vaccination rates among the urban population in China call for multiple measures to strengthen health education and vaccination recommendations for residents, especially for the elderly, low-education and low-income populations.PMID:37380410 | DOI:10.3760/cma.j.cn112338-20221125-00998
Source: Herpes - June 28, 2023 Category: Infectious Diseases Authors: M Wang C Long M Z Hu Y S Wang Y Q Xia B B Yuan D W Zhu P He Source Type: research
Willingness to Vaccinate Against Herpes Zoster and Its Associated Factors Across WHO Regions: Global Systematic Review and Meta-Analysis
CONCLUSIONS: Only 1 in 2 individuals showed a willingness to be vaccinated against HZ. The willingness rate was the highest in the Eastern Mediterranean Region. Our findings show the critical role HCWs play in promoting HZ vaccination. Monitoring HZ vaccination willingness is necessary to inform public health decision-making. These findings provide critical insights for designing future life-course immunization programs.PMID:36892937 | DOI:10.2196/43893
Source: Herpes - March 9, 2023 Category: Infectious Diseases Authors: Qiang Wang Liuqing Yang Lan Li Chang Liu Hui Jin Leesa Lin Source Type: research
Addressing racial inequality and its effects on vaccination rate: A trial comparing a pharmacist and peer educational program (MOTIVATE) in diverse older adults
CONCLUSIONS: Both interventions significantly improved knowledge and trust toward vaccination and retained their effect 1 month after the program. The 2 effective community-based education models should be expanded to ensure timely and trusted information is available to educate older adults about vaccine-preventable diseases. Further research is encouraged to assess the long-term cost-effectiveness of these models' utilization on a larger scale. DISCLOSURES: Dr Schafer is an employee of Merck; however, at the time of the project, he was a professor at Thomas Jefferson University. The other authors have no conflicts of int...
Source: Herpes - July 31, 2023 Category: Infectious Diseases Authors: Katherine M Prioli Ayse Akincigil Tarlan Namvar Jocelyn Mitchell-Williams Jason J Schafer Renee C Cunningham Lynn Fields-Harris Megan McCoy Ronald Vertsman Ashley Guesnier Laura T Pizzi Source Type: research
Vaccination against the herpes zoster virus
CONCLUSIONS: We have a safe and effective vaccine against the herpes zoster virus that allows us to protect the most vulnerable population groups against this virus.PMID:37573820 | PMC:PMC10428030 | DOI:10.1016/j.aprim.2023.102710
Source: Atencion Primaria - August 13, 2023 Category: Primary Care Authors: Jos é Javier Gómez Marco Susana Mart ín Martín Pablo Aldaz Herce Ana Pilar Javierre Miranda Coro S ánchez Hernández Source Type: research
Reactivation of Herpes Zoster Virus After COVID-19 Vaccination: Is There Any Association?
We report 10 incidences of herpes zoster reactivation within 7-21 days of getting the COVID-19 vaccination. Transient immunomodulation following vaccination, similar to that seen in COVID-19 illness, could be one explanation for this reactivation. These cases highlight the significance of continuing to examine vaccine safety during the COVID-19 pandemic's ongoing mass vaccination campaign. We also underline the importance of peripheral health professionals in the management and reporting of any vaccination-associated adverse event.PMID:35746994 | PMC:PMC9209775 | DOI:10.7759/cureus.25195
Source: Herpes - June 24, 2022 Category: Infectious Diseases Authors: Surbhi Agrawal Kapila Verma Ishan Verma Jagriti Gandhi Source Type: research
